Antiphospholipid Syndrome (APS): Definition, Criteria, and Management

Definition

APS is a systemic autoimmune disorder characterized by arterial or venous thrombosis or pregnancy morbidity in the presence of persistent antiphospholipid antibodies (aPL).

Classification Criteria (Sydney 2006)

Clinical (1 required):

  • Vascular thrombosis (arterial, venous, any organ)
  • Pregnancy morbidity:
    • ≥1 unexplained fetal death ≥10 weeks
    • ≥1 premature birth <34 weeks due to eclampsia, preeclampsia, or placental insufficiency
    • ≥3 unexplained consecutive embryonic losses <10 weeks

Laboratory (1 required, on 2 occasions ≥12 weeks apart):

  • Lupus anticoagulant (LA)
  • Anti-cardiolipin IgG/IgM (>40 GPL/MPL or >99th percentile)
  • Anti-β2-glycoprotein I IgG/IgM (>99th percentile)

Primary vs. Secondary

  • Primary: No other autoimmune disease
  • Secondary: Associated with SLE (most common), RA, Sjögren's, etc.

Clinical Manifestations

  • Thrombosis: DVT/PE, stroke, TIA, MI, livedo reticularis
  • Obstetric: Recurrent loss, preeclampsia, IUGR, placental abruption
  • Non-criteria: Thrombocytopenia, hemolytic anemia, nephropathy, cardiac valve lesions, cognitive dysfunction

Management

  • Thrombosis: Lifelong anticoagulation (warfarin INR 2–3; DOACs controversial—avoid in triple-positive)
  • Pregnancy: Prophylactic LMWH + low-dose aspirin throughout
  • Primary prevention (aPL+ only): Aspirin 81 mg; consider hydroxychloroquine
  • Catastrophic APS (CAPS): ICU, anticoagulation, high-dose steroids, plasma exchange, IVIG, rituximab

Kidney Disease - Related Articles